Elevated serum antibody titers to Epstein‐Barr virus in HTLV‐I‐associated myelopathy (HAM)
- 1 October 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 38 (10) , 1650
- https://doi.org/10.1212/wnl.38.10.1650
Abstract
We studied the serum antibody titers to Epstein-Barr virus (EBV) in 11 patients with HTLV-I-associated myelopathy (HAM). HAM patients showed significant increases in IgG antibodies to EBV-capsid antigen (VCA) and -early antigen (EA) and in VCA-specific IgA compared with 25 seronegative subjects. However, there were no significant differences in antibodies to EBV-nuclear antigen (EBNA) or to other viruses between the two groups. In HAM patients, altered antibody responses occurred specifically to EBV-associated antigens, not to other viruses.This publication has 6 references indexed in Scilit:
- Altered subsets of peripheral blood lymphocytes in patients with HTLV‐I associated myelopathy (HAM)Neurology, 1988
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- Enhanced Serological and Virological Findings of Epstein-Barr Virus in Patients with AIDS and AIDS-Related ComplexThe Journal of Infectious Diseases, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985
- Alteration of T-Cell Functions by Infection with HTLV-I or HTLV-IIScience, 1984
- Epstein‐barr virus‐specific antibodies in patients with adult T‐cell leukemia (ATL) and healthy ATL virus‐carriersInternational Journal of Cancer, 1983